| Filing | Description | Date Filed  |
Size | ||||
|---|---|---|---|---|---|---|---|
| 424B5 | prospectus filed pursuant to rule 424 | Mar 17, 2010 | 572.5 KB | ||||
| 8-K | current report | Mar 17, 2010 | 19.1 KB | ||||
| 4 | waltrip, william h | Mar 1, 2010 | 19.5 KB | ||||
| 4 | blum, leonard m | Feb 26, 2010 | 20.4 KB | ||||
| 10-K | annual report | Feb 26, 2010 | 924.2 KB | ||||
| 4 | aguiar, michael w | Feb 23, 2010 | 18.8 KB | ||||
| 4 | blum, leonard m | Feb 23, 2010 | 18.8 KB | ||||
| 4 | brinkley, david l | Feb 23, 2010 | 18.8 KB | ||||
| 4 | mammen, mathai | Feb 23, 2010 | 18.8 KB | ||||
| 4 | shafer, bradford j | Feb 23, 2010 | 21.0 KB | ||||
| 4 | winningham, rick e | Feb 23, 2010 | 18.7 KB | ||||
| SC 13G/A | amended statement of beneficial ownership | Feb 16, 2010 | 26.6 KB | ||||
| 4 | shafer, bradford j | Feb 12, 2010 | 20.9 KB | ||||
| 4 | mammen, mathai | Feb 12, 2010 | 18.7 KB | ||||
| 4 | brinkley, david l | Feb 12, 2010 | 18.7 KB | ||||
| 4 | blum, leonard m | Feb 12, 2010 | 18.7 KB | ||||
| 4 | aguiar, michael w | Feb 12, 2010 | 18.7 KB | ||||
| 4 | winningham, rick e | Feb 12, 2010 | 18.7 KB | ||||
| 5 | levine arnold j | Feb 12, 2010 | 19.0 KB | ||||
| SC 13G/A | amended statement of beneficial ownership | Feb 12, 2010 | 58.1 KB | ||||
|
|||||||
VIBATIV is a trademark of Astellas Pharma Inc.
RELOVAIR is a trademark of Glaxo Group Ltd.
Terms of Use Website Admin Contact Theravance Contact Site Map